[1] Choi YM,Kim TY,Song DE,et al.Papillary thyroid carcinoma arising from a thyroglossal duct cyst:a single institution experience [J].Endocr J,2013,60(5):665-670.
[2] Kim TH,Park YJ,Lim JA,et al.The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer:a meta-analysis [J].Cancer,2012,118(7):1764-1773.
[3] Park WS,Chung KW,Young MS,et al.Differential protein expression of lymph node metastases of papillary thyroid carcinoma harboring the BRAF mutation [J].Anticancer Res,2013,33(10):4357-4364.
[4] Mordalska A,Latek J,Ferenc T,et al.Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes [J].Thyroid Res,2010,3(1):6.
[5] Wojciechowska-Durczynska K,Krawczyk-Rusiecka K,Cyniak-Magierska A,et al.Relative quantification of PIK3CA gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non toxic goitre by real-time RT-PCR [J].Thyroid Res,2010,3(1):5.
[6] Schmitt AC,Cohen C,Siddiqui MT.Paired box gene 8,HBME-1,and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma:diagnostic utility [J].Cancer Cytopathol,2010,118(4):196-202.
[7] Gong RX,Gong YP,Yang J,et al.Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography [J].Genet Mol Res,2013,12(4):4990-4997.
[8] Lee EK,Chung KW,Yang SK,et al.DNA Methylation of MAPK Signal-inhibiting Genes in Papillary Thyroid Carcinoma [J].Anticancer Res,2013,33(11):4833-4839.
[9] Xing M.BRAF mutation in papillary thyroid cancer:pathogenic role,molecular bases,and clinical implications [J].Endocr Rev,2007,28(7):742-762.
[10] Goutas N,Vlachodimitropoulos D,Bouka M,et al.BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort [J].Anticancer Res,2008,28(1A):305-308.
[11] Fukushima T,Takenoshita S.Roles of RAS and BRAF mutations in thyroid carcinogenesis [J].Fukushima J Med Sci,2005,51(2):67-75.